We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
An in-depth guide to Descovy, covering its use for HIV prevention (PrEP) and treatment in India. Learn about how it works, side effects, dosage, and important safety information.

In the ongoing fight against HIV, advancements in medication play a pivotal role. Descovy, a prescription medication, has emerged as a significant tool for both preventing HIV infection and managing existing HIV. This guide aims to provide clear, practical information about Descovy for readers in India, covering its uses, how it works, potential side effects, and what you need to know about incorporating it into your health regimen.
Descovy is an oral tablet that contains two active ingredients: emtricitabine and tenofovir alafenamide. These belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs work by interfering with the way the HIV virus replicates itself within the body, effectively reducing its ability to multiply and spread.
It's important to understand that Descovy is a brand-name medication. As of now, a generic version is not available in India. This means that the cost might be a consideration for some individuals, and it's always wise to discuss financial aspects with your healthcare provider or pharmacist.
Descovy targets the HIV virus directly. When HIV enters the body, it attempts to make copies of itself to spread. Descovy, by inhibiting a key enzyme called reverse transcriptase, disrupts this copying process. This action helps to lower the amount of HIV in your body, which is often referred to as the viral load. Lowering the viral load is essential for managing HIV and improving overall health outcomes.
Descovy has two primary uses, each serving a distinct but equally important purpose in HIV management:
PrEP is a strategy for individuals who do not have HIV but are at a higher risk of contracting it. Taking Descovy as PrEP daily can significantly reduce the risk of acquiring HIV infection. It acts as a protective shield, making it much harder for the virus to establish itself in the body if exposure occurs.
Who is PrEP for?
Important Note for PrEP in India: Descovy is approved for PrEP in adults and adolescents (12 years and older) weighing at least 35 kg (approximately 77 lbs). However, it is not recommended for females at risk of HIV from vaginal sex when used for PrEP. This is a critical distinction to remember, and your doctor will guide you based on your specific risk factors and anatomy.
For individuals already living with HIV, Descovy is prescribed as part of a combination therapy. It is taken daily along with other antiretroviral medications. The goal of this combination therapy is to suppress the HIV virus, reduce the viral load to undetectable levels, and allow the immune system to recover. It's vital to remember that Descovy, like other HIV treatments, does not cure HIV, but it effectively manages the condition, allowing individuals to lead long, healthy lives.
Children and HIV Treatment: Descovy can be prescribed for HIV treatment in children who weigh at least 35 kg (77 lbs). However, certain other antiretroviral drugs are not recommended for children weighing less than 35 kg when taken with Descovy.
Descovy is an oral tablet that you swallow whole. It is typically taken once a day. The dosage remains the same for both PrEP and HIV treatment: one (200 mg/25 mg) tablet daily. It is crucial to take Descovy exactly as prescribed by your doctor. Missing doses or not taking it consistently can reduce its effectiveness and potentially lead to drug resistance.
Scenario: Priya, a young woman in Delhi, is concerned about her partner's HIV status. Her doctor has discussed PrEP with her and prescribed Descovy. She understands that she needs to take one tablet every day, even on days when she feels perfectly healthy, to maintain the protective effect. She sets a daily reminder on her phone to ensure she never misses a dose.
Descovy comes with important safety information, including what are known as “boxed warnings.” These are the strongest warnings that the U.S. Food and Drug Administration (FDA) requires on prescription drug labels. For Descovy, these include:
Always discuss any pre-existing health conditions, especially liver conditions like Hepatitis B, with your doctor before starting Descovy.
Like all medications, Descovy can cause side effects. While many people tolerate it well, it's good to be aware of what you might experience. Common side effects can include:
Less common but more serious side effects can occur. These might include:
If you experience any severe or persistent side effects, or if you have concerns about your symptoms, contact your doctor immediately. Do not stop taking Descovy without consulting your healthcare provider.
It is crucial to inform your doctor about all the medications, supplements, and herbal products you are currently taking. Some drugs can interact with Descovy, potentially affecting its efficacy or increasing the risk of side effects. Your doctor will review your medication list to ensure Descovy is safe for you.
If you suspect you have taken too much Descovy, contact your doctor right away. You can also reach out to a poison control center. However, if you experience severe symptoms such as difficulty breathing, severe dizziness, or loss of consciousness, call emergency services (like 108 or 112 in India) or go to the nearest hospital emergency room immediately.
If you are taking Descovy for HIV treatment, your doctor will likely monitor the amount of HIV in your body (viral load) periodically. Studies have shown that most people experience reduced viral loads within 24 weeks of starting treatment. Regular check-ups are essential to ensure the medication is working effectively and to monitor for any potential side effects or changes in your health.
While Descovy is a powerful tool for HIV prevention and treatment, it's part of a broader strategy. Remember that consistent use of condoms during sexual activity, avoiding the sharing of needles, and regular HIV testing are also vital components of HIV prevention. PrEP significantly reduces risk, but it does not eliminate it entirely. A comprehensive approach is always best.
No, Descovy does not cure HIV. It is a treatment that helps manage the virus by suppressing its replication, allowing individuals to live longer, healthier lives. HIV is a chronic condition that requires lifelong management.
Descovy is approved for PrEP in adults and adolescents (12 years and older) weighing at least 35 kg. However, it is specifically not recommended for females at risk of HIV from vaginal sex when used for PrEP. Your doctor will assess your individual risk and recommend the most appropriate prevention strategy.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are unsure, contact your doctor or pharmacist for guidance.
The duration of Descovy treatment depends on whether you are taking it for PrEP or HIV treatment. For PrEP, it is typically taken daily as long as you remain at risk of HIV exposure. For HIV treatment, it is usually a lifelong medication taken in combination with other drugs. Your doctor will determine the appropriate duration based on your health status and needs.
It is essential to consult with a healthcare professional in the following situations:
Your doctor is your best resource for personalized medical advice. They can assess your individual health situation and guide you on the appropriate use of Descovy in the context of HIV prevention and management in India.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026

Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026